Adalank
Adamantane-Selank · Adamantyl-Selank
Adamantane-modified Selank analog - the Selank twin of Adamax. Search volume exists; dedicated papers do not. Parent Selank evidence does not transfer to an adamantyl conjugate. Treat half-life and dose as vendor folklore.
Quick answer
What it is: Adamantane-modified Selank analog - the Selank twin of Adamax.
Typical research dose: 200-750 mcg/day (intranasal; vendor protocols only)
Research summary, not medical advice.
Use-case scores
- Cognition2.5/10
Compound card
- Sequence
- Adamantane-conjugated Selank (vendor structure; confirm COA)
- Class
- Uncharacterized Selank conjugate
- Formula
- Adamantane-Selank (vendor)
- Status
- Not FDA-approved · research use
How it works
Adalank is marketed as adamantane-conjugated Selank - the Selank twin of Adamax. Adamantane can raise lipophilicity. Transferring Selank’s GABA/enkephalin papers onto this conjugate without PK is a category error.
We list it because vendors sell it and people search it. Half-life on this page is explicitly unknown.
Source: Parent compound: Selank. Adalank: no indexed human PK as of 2026.
No published human PK
Dose and duration numbers on vendor pages are not citations. Read Selank. Treat this as an uncharacterized analog, like Adamax.
Research Use Cases
- ✓Nootropic analog SKU: Low
Dosing
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Vendor nasal range only | 200–750 mcg/day | 1–2× daily | Folklore. Not a label. |
Administration
Timeline
Who it is for
Nootropic analog SKU
LowHigh search, near-zero papers. Listed for identity and recon, not endorsement.
Reconstitution
Safety & Considerations
Unknown human safety file. Nasal irritation possible. Adamantane moieties have CNS/renal baggage in other drugs - not characterized here.
Regulatory & Legal Status
Adamantane-Selank analog. No indexed human PK or approval
Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Limits of current evidence
- No published human PK.
- Do not inherit Selank’s Russian-trial score.
Verdict
Adalank is the Selank twin of Adamax. Uncharacterized analog. Read Selank.
Interactions & Contraindications
Unknown human safety file. Nasal irritation possible. Adamantane moieties have CNS/renal baggage in other drugs - not characterized here.
Adalank vs. Adamax
Canonical comparison: Adalank vs Adamax
| Attribute | Adalank | Adamax |
|---|---|---|
| Parent | Selank (tuftsin analog) | Semax (ACTH 4–10 analog) |
| Human PK | None indexed | None indexed |
| Modification | Adamantane conjugate (vendor) | Adamantane conjugate (vendor) |
Verdict: Twins on a catalog, both uncharacterized. Read the parent (Selank vs Semax), not the adamantane prefix.
Frequently Asked Questions
Is Adalank the same as Adamax?▼
Prescription options: compare licensed telehealth providers
Some peptide therapies are available only by prescription after a consult with a licensed clinician.
